Heparin Sodium Market By Application ( Treatment of Venous Thromboembolism, Pregnancy, Cardioversion of Atrial Fibrillation/Flutter), Industry Trends,Estimation and Forecast, 2017-2025

February 2018

 Pages: 175

 ERC 3406


Heparin Sodium Market is projected to grow with CAGR of 7.9% during the forecast period of 2017 to 2025.In 2017, the Cardioversion of Atrial Fibrillation/Flutter segment generated the highest revenue share in the global heparin sodium market. 

Heparin is an anticoagulant that prevents blood from clotting. It does not dissolve the existing blood clots but averts it from expanding and causing serious problems. Heparin finds its major application in various medical processes, owing to its ability to prevent blood from clotting during surgeries, dialysis and transfusions. Patients undergoing surgeries or those that have been subjected to complete bed rest for long period of time are given low doses of heparin, in order to prevent blood clots. Heparin may also be used to diagnose and treat a serious blood condition called disseminated intravascular coagulation.

Market Determinants

The major factors driving the market growth are increase in the incidence of thrombosis, rising awareness among the patient population regarding the availability of such treatment options, and rise in government funding towards improving healthcare facilities. However, stringent government regulations might hinder the market growth.

Heparin Sodium Market
Segment Analysis

The global heparin sodium market is segmented on the basis of application and geography. By type, the market is segmented as treatment of venous thromboembolism, pregnancy, cardio version of atrial fibrillation, and others. Geographically, the market is segmented into North America, Europe, China, Japan, India, and Southeast Asia.


Heparin Sodium Market

Some major market players of the sodium heparin market are Shenzhen Hepalink, Bioibérica, Nanjing King-Friend, Pfizer, SPL, Dongcheng Biochemicals, Changzhou Qianhong Bio-Pharma, Changshan Biochemical, Pharma Action, Baxter, Dongying Tiandong Pharmaceutical, Opocrin, Aspen Oss, Xinbai Pharmaceuticals, Yino Pharma Limited, and Sichuan Deebio.


By Application
   • Treatment of Venous Thromboembolism
   • Pregnancy
   • Cardioversion of Atrial Fibrillation/Flutter
   • Others

By Region
   • North America
   • China
   • Europe
   • Japan
   • India
   • Southeast Asia


   • Shenzhen Hepalink
   • Bioibérica
   • Nanjing King-Friend
   • Pfizer
   • SPL
   • Dongcheng Biochemicals
   • Changzhou Qianhong Bio-Pharma
   • Changshan Biochemical
   • Pharma Action
   • Baxter
   • Dongying Tiandong Pharmaceutical
   • Opocrin
   • Aspen Oss
   • Xinbai Pharmaceuticals
   • Yino Pharma Limited
   • Sichuan Deebio

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Heparin Sodium Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Heparin Sodium Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!